LAUSR

Previous studies have shown that propofol (PPF) plays a protective role in ischemia–reperfusion (I/R) in multiple organs and tissues. This study was aimed to explore the mechanism of PPF in ameliorating myocardial ischemia‐reperfusion injury (MIRI). MIRI model was established with Sprague–Dawley rats, and PPF pretreatment was performed before reperfusion. Creatine kinase isoform (CK‐MB), lactate dehydrogenase (LDH), and hematoxylin and eosin stain were used to evaluate the severity of MIRI. H9c2 cells were treated with hypoxia/reoxygenation (H/R) to simulate I/R injury in vitro. Real‐time quantitative polymerase chain reaction (qPCR) was employed to assess MALAT1 and microRNA (miR)−206 expressions. Autophagy‐related 3 (ATG3), LC3BⅡ/LC3BⅠ, and Beclin‐1 expression were examined by western blot. Apoptosis was monitored using flow cytometry. Interaction between MALAT1 and miR‐206 was determined by bioinformatics analysis, dual‐luciferase reporter gene assay, RIP assay, and RNA pull‐down assay. PPF pretreatment remarkably reduced CK‐MB level, LDH level, myocardial infarct size, and LC3BⅡ/LC3BⅠ ratio and Beclin‐1 expression in the rats with MIRI, and repressed the apoptosis of H9c2 cells exposed to H/R. PPF pretreatment markedly suppressed MALAT1 expression and enhanced miR‐206 expression in both in vivo and in vitro models. MiR‐206 was identified as a target of MALAT1 in cardiomyocytes, and MALAT1 could increase the expression of ATG3. Additionally, the upregulation of MALAT1 partially reversed the protective effect of PPF on cardiomyocytes in vitro. PPF modulated MALAT1/miR‐206/ATG3 axis to protect cardiomyocytes against I/R injury.